Our company aspires to be open and transparent about how we operate in order to earn and retain the trust and confidence of our customers, employees, shareholders and other important stakeholders.
In light of the international transparency initiatives already underway and the potential for similar developments in Canada, Innovative Medicines Canada has designed a Voluntary Framework on Disclosure of Payments for Member companies who choose to voluntarily adopt it. Merck is moving forward with voluntary disclosure of payments and will be engaging stakeholders in related discussions.
A detailed description of each category can be found in the Voluntary Framework on Disclosure of Payments, developed by Innovative Medicines Canada.